2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 出版社推荐： | 热 美国化学会ACS期刊一览 | 新 IF 2.9，JCR Q2 神经系统基础研究期刊征稿中 | 新 开放获取选刊时如何避雷？点击查看干货指南！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Acta Pharmaceutica Sinica B ACTA PHARM SIN B （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.4
83人评分
我要评分
声誉 8.9 影响力 7.8 速度 8.5 | |||||||||||||||||||||
| 期刊ISSN | 2211-3835 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| E-ISSN | 2211-3843 | |||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 14.7 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：10.957 | |||||||||||||||||||||
| 2023-2024自引率 | 5.40%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 14.1 | |||||||||||||||||||||
| JCI期刊引文指标 | 3.61 | |||||||||||||||||||||
| h-index | 28 | |||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b | |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/apsb/default.aspx | |||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/publish/guide-for-authors | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Acta Pharmaceutica Sinica B的语言要求，还能让Acta Pharmaceutica Sinica B编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Acta Pharmaceutica Sinica B编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（2篇） 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ Full Length Articles and Reviews - USD2600; Short Articles - USD2000; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 10005 | |||||||||||||||||||||
| 出版商 | Elsevier BV | |||||||||||||||||||||
| 涉及的研究方向 | Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics | |||||||||||||||||||||
| 出版国家或地区 | CHINA MAINLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2011 | |||||||||||||||||||||
| 年文章数 | 300点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 98.22% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 76.00% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days; 网友分享经验： 19 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 来源Elsevier官网： 9% | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ Full Length Articles and Reviews - USD2600; Short Articles - USD2000; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Acta Pharmaceutica Sinica B顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 编辑信息 |
Editor-in-Chief Jian-Dong Jiang Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Materia Medica, Beijing, China Co-Editor-in-Chief Rui Wang China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Associate Editors-in-Chief Xin-Xin Ding The University of Arizona, Tucson, Arizona, United States of America Shi-lin Chen China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Wen-Xing Ding University of Kansas Medical Center, Kansas City, Kansas, United States of America De-An Guo China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Hongmin Li The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, United States of America Rong-Guang Shao Chinese Academy of Medical Sciences Institute of Medicinal Biotechnology and Peking Union Medical College, Beijing, China Jian-Gong Shi China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China Duxin Sun University of Michigan College of Pharmacy, Ann Arbor, Michigan, United States Xiao-Liang Wang China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China Wen Xie University of Pittsburgh, School of Pharmacy, Department of Pharmaceutical Sciences, Pittsburgh, Pennsylvania, United States of America Jian-Ping Ye Shanghai Institute of Diabetes, Shanghai, China Jianhua Zhang The University of Alabama at Birmingham, Birmingham, Alabama, United States of America Haining Zhu The University of Arizona College of Pharmacy, Tucson, Arizona, United States of America Qiang Zhang Peking University School of Pharmaceutical Sciences, Beijing, China | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Late-stage cascade of oxidation reactions during the biosynthesis of oxalicine B in Penicillium oxalicum Author: Zhang, Tao; Gu, Guowei; Liu, Guodong; Su, Jinhua; Zhan, Zhilai; Zhao, Jianyuan; Qian, Jinxiu; Cai, Guowei; Cen, Shan; Zhang, Dewu; Yu, Liyan Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 256-270. DOI: 10.1016/j.apsb.2022.09.008 PubMed DOI |
| 2. | Actively separated microneedle patch for sustained-release of growth hormone to treat growth hormone deficiency Author: Yang, Li; Liu, Qingyun; Wang, Xinhui; Gao, Nansha; Li, Xiuzhen; Chen, Hongzhong; Mei, Lin; Zeng, Xiaowei Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 344-358. DOI: 10.1016/j.apsb.2022.04.015 PubMed DOI |
| 3. | Dihydrotanshinone I preconditions myocardium against ischemic injury via PKM2 glutathionylation sensitive to ROS Author: Wu, Xunxun; Liu, Lian; Zheng, Qiuling; Ye, Hui; Yang, Hua; Hao, Haiping; Li, Ping Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 113-127. DOI: 10.1016/j.apsb.2022.07.006 PubMed DOI |
| 4. | Chlorella sp.-ameliorated undesirable microenvironment promotes diabetic wound healing Author: Wu, Hangyi; Yang, Pei; Li, Aiqin; Jin, Xin; Zhang, Zhenhai; Lv, HuiXia Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 410-424. DOI: 10.1016/j.apsb.2022.06.012 PubMed DOI |
| 5. | Bilayer hydrogel dressing with lysozyme-enhanced photothermal therapy for biofilm eradication and accelerated chronic wound repair Author: Wang, Yizhen; Lv, Qijun; Chen, You; Xu, Langtao; Feng, Miao; Xiong, Zhiyong; Li, Jiajun; Ren, Jie; Liu, Jie; Liu, Bo Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 284-297. DOI: 10.1016/j.apsb.2022.03.024 PubMed DOI |
| 6. | PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism Author: Sun, Mingming; Li, Leilei; Niu, Yujia; Wang, Yingzhi; Yan, Qi; Xie, Fei; Qiao, Yaya; Song, Jiaqi; Sun, Huanran; Li, Zhen; Lai, Sizhen; Chang, Hongkai; Zhang, Han; Wang, Jiyan; Yang, Chenxin; Zhao, Huifang; Tan, Junzhen; Li, Yanping; Liu, Shuangping; Lu, Bin; Liu, Min; Kong, Guangyao; Zhao, Yujun; Zhang, Chunze; Lin, Shu-Hai; Luo, Cheng; Zhang, Shuai; Shan, Changliang Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 157-173. DOI: 10.1016/j.apsb.2022.05.019 PubMed DOI |
| 7. | Sialic acid-mediated photochemotherapy enhances infiltration of CD8D T cells from tumor-draining lymph nodes into tumors of immunosenescent mice Author: Sui, Dezhi; Li, Changzhi; Tang, Xueying; Meng, Xianmin; Ding, Junqiang; Yang, Qiongfen; Qi, Zhaowei; Liu, Xinrong; Deng, Yihui; Song, Yanzhi Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 425-439. DOI: 10.1016/j.apsb.2022.06.005 PubMed DOI |
| 8. | Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation Author: Nie, Qiang; Li, Chenwen; Wang, Yu; Hu, Yi; Pu, Wendan; Zhang, Qixiong; Cai, Jiajun; Lin, Yongyao; Li, Gang; Wang, Chenping; Li, Lanlan; Dou, Yin; Zhang, Jianxiang Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 390-409. DOI: 10.1016/j.apsb.2022.07.013 PubMed DOI |
| 9. | All-stage targeted therapy for the brain metastasis from triple-negative breast cancer Author: Luo, Zimiao; Wu, Sunyi; Zhou, Jianfen; Xu, Weixia; Xu, Qianzhu; Lu, Linwei; Xie, Cao; Liu, Yu; Lu, Weiyue Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 359-371. DOI: 10.1016/j.apsb.2022.03.0262211-3835 PubMed DOI |
| 10. | Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy Author: Liu, Zimo; Zhou, Xuefei; Li, Qi; Shen, Youqing; Zhou, Tianhua; Liu, Xiangrui Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 327-343. DOI: 10.1016/j.apsb.2022.05.010 PubMed DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
